{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:51:40Z","timestamp":1778327500395,"version":"3.51.4"},"reference-count":0,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2001,1,2]],"date-time":"2001-01-02T00:00:00Z","timestamp":978393600000},"content-version":"unspecified","delay-in-days":93,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2000,10]]},"abstract":"<jats:p>WHO has adopted a goal of eliminating indigenous measles from the European Region by the \nyear 2007. The strategy focuses on reducing the proportion of susceptible individuals in the \npopulation to low levels and maintaining these low levels of susceptibility. Routine vaccination \nagainst measles for children aged 13\u201315 months was introduced in Poland in 1975, and a \nsecond dose added in 1991. High coverage (&gt; 95%) is achieved with both doses. In order to \nassess progress towards measles elimination in Poland, a serological survey was performed to \nevaluate the impact of vaccination on the susceptibility profile of population. Three thousand \nresidual serum samples from individuals aged 1\u201330 years were collected from hospitals in six \nselected voivodeships (administration units) in Poland. These were tested for measles-specific \nIgG using a commercial ELISA. Overall 4% (120\/3000) were negative for measles virus \nantibody. The highest proportion of negatives (8\u00b72%) occurred among cohorts born 1977\u201381 \u2013 \nthe only cohorts in which susceptibility exceeded the WHO targets. \u2018Catch-up\u2019 vaccination \nstrategies should target these cohorts.<\/jats:p>","DOI":"10.1017\/s0950268899004616","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T13:23:42Z","timestamp":1027776222000},"page":"385-392","source":"Crossref","is-referenced-by-count":14,"title":["The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population"],"prefix":"10.1017","volume":"125","author":[{"given":"W.","family":"JANASZEK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"GUT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J.","family":"GAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2001,1,2]]},"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268899004616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T20:15:21Z","timestamp":1557346521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268899004616\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["S0950268899004616"],"URL":"https:\/\/doi.org\/10.1017\/s0950268899004616","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}